Neurological Aspects of Syncope and Orthostatic Intolerance

Medical Clinics of North America

Volumn 93, Issue 2, 2009, Pages 427-449

  Weimer, Louis H ^a   Zadeh, Pezhman ^a  

^a NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Autonomic neuropathy; Carotid sinus syndrome; Multiple system atrophy; Orthostatic hypotension; POTS; Vasodepressor; Vasovagal

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DISOPYRAMIDE; ETILEFRINE; FLUDROCORTISONE; FLUOXETINE; METHYLPHENIDATE; METOPROLOL; MIDODRINE; PAROXETINE; SCOPOLAMINE; SERTRALINE; THEOPHYLLINE; VERAPAMIL;

AUTONOMIC NEUROPATHY; BRADYCARDIA; CAROTID SINUS MASSAGE; CAROTID SINUS SYNDROME; CONVULSION; COUGHING; DIABETIC NEUROPATHY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; EPILEPSY; EXERCISE; GLOSSOPHARYNGEAL NEURALGIA; HEAD TILTING; HEART DISEASE; HEART PACING; HUMAN; LABORATORY TEST; LUNG DISEASE; MICTURITION; NEUROIMAGING; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PATHOGENESIS; PERIPHERAL NEUROPATHY; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; SEIZURE; SYNCOPE; TACHYCARDIA; TILT TABLE TEST;

HUMANS; NEUROLOGIC EXAMINATION; ORTHOSTATIC INTOLERANCE; SYNCOPE; TILT-TABLE TEST;

EID: 61449236383     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2008.10.002     Document Type: Review

References (131)

1. Kapoor W.N. Syncope. N Engl J Med 343 (2000) 1856-1862
2. Lempert T., Bauer M., and Schmidt D. Syncope: a videometric analysis of 56 episodes of transient cerebral hypoxia. Ann Neurol 36 (1994) 233-237
3. Raj S.R., and Sheldon R.S. Permanent cardiac pacing to prevent vasovagal syncope. Curr Opin Cardiol 17 (2002) 90-95
4. Kaufmann H. Neurally mediated syncope: pathogenesis, diagnosis, and treatment. Neurology 45 Suppl 5 (1995) S12-S18
5. Abboud F.M. Neurocardiogenic syncope. N Engl J Med 328 (1993) 1117-1120
6. Bloomfield D., Maurer M., and Bigger Jr. J.T. Effects of age on outcome of tilt-table testing. Am J Cardiol 83 (1999) 1055-1058
7. Mathias C.J., Deguchi K., Bleasedale-Barr K., et al. Familial vasovagal syncope and pseudosyncope: observations in a case with both natural and adopted siblings. Clin Auton Res 10 (2000) 43-45
8. Mosqueda-Garcia R., Furlan R., Tank J., et al. The elusive pathophysiology of neurally mediated syncope. Circulation 102 (2000) 2898-2906
9. Lewis T. Vasovagal syncope and the carotid sinus mechanism. Br Med J 1 (1932) 873-876
10. El-Bedawi K.M., Wahbha M.A., and Hainsworth R. Cardiac pacing does not improve orthostatic tolerance in patients with vasovagal syncope. Clin Auton Res 4 (1994) 233-237
11. Oberg B., and Thoren P. Increased activity in the left ventricular receptors during hemorrhage or occlusion of caval veins in the cat; a possible cause of the vasovagal reaction. Acta Physiol Scand 85 (1972) 164-173
12. Norcliffe-Kaufmann L.J., Kaufmann H., and Hainsworth R. Enhanced vascular responses to hypocapnia in neurally mediated syncope. Ann Neurol 63 3 (2008) 288-294
13. Alboni P., Alboni M., and Bertorelle G. The origin of vasovagal syncope: to protect the heart or to escape predation?. Clin Auton Res 18 4 (2008) 170-178
14. Parry S.W., and Kenny R.A. Carotid sinus syndrome masquerading as treatment resistant epilepsy. Postgrad Med J 76 (2000) 656-658
15. Davies A.J., Steen N., and Kenny R.A. Carotid sinus hypersensitivity is common in older patients presenting to an accident and emergency department with unexplained falls. Age Ageing 30 (2001) 289-293
16. Sutton R., Petersen M., Brignole M., et al. Proposed classification for tilt induced vasovagal syncope. Eur J Card Pacing Electrophysiol 3 (1992) 180-183
17. Sutton R., Brignole M., Menozzi C., et al. Dual chamber pacing in the treatment of neurally mediated tilt positive cardioinhibitory syncope. Pacemaker versus no therapy- a multicenter randomized study. The vasovagal syncope international study (VASIS) investigators. Circulation 102 (2000) 294-299
18. O'Mahony D. Carotid sinus hypersensitivity in old age: clinical syndrome or physical sign?. Age Ageing 30 (2001) 273-274
19. Allan L.M., Ballard C.G., Allen J., et al. Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatr 78 7 (2007) 671-677
20. Kenny R.A., Shaw F.E., O'Brien J.T., et al. Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions. J Neurol Neurosurg Psychiatr 75 7 (2004) 966-971
21. Kenny R.A. Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). J Am Coll Cardiol 38 (2001) 1491-1496
22. Hilal H., and Massumi R. Fatal ventricular fibrillation during carotid sinus stimulation. N Engl J Med 275 (1966) 157-158
23. Haslam R.H., and Freigang B. Cough syncope mimicking epilepsy in asthmatic children. Can J Neurol Sci 12 (1985) 45-47
24. Mattle H.P., Nirkko A.C., Baumgartner R.W., et al. Transient cerebral circulatory arrest coincides with fainting in cough syncope. Neurology 45 (1995) 498-501
25. Gelisse P., and Genton P. Cough syncope misinterpreted as epileptic seizure. Epileptic Disord 10 3 (2008) 223-224
26. Lyle C.B., Monroe J.T., Flinn D.E., et al. Micturition syncope: a report of 24 cases. N Engl J Med 265 (1961) 982-986
27. Proudfit W.L., and Forteza M.E. Micturition syncope. N Engl J Med 260 (1959) 328-331
28. Kapoor W.N., Peterson J.R., and Karpf M. Micturition syncope: a reappraisal. JAMA 253 (1985) 796-798
29. Riley H.A., German W.J., Wortis H., et al. Glossopharyngeal neuralgia initiating or associated with cardiac arrest. Trans Am Neurol Assoc 68 (1942) 28-29
30. Wallin B.G., Westerberg C., and Sundlof G. Syncope induced by glossopharyngeal neuralgia. Sympathetic outflow to muscle. Neurology 34 (1984) 522-524
31. Zaidi A., Clough P., Cooper P., et al. Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause. J Am Coll Cardiol 36 (2000) 181-184
32. Gastaut H., and Fischer-Williams M. Electroencephalographic study of syncope: its differentiation from epilepsy. Lancet 2 (1957) 1018-1025
33. Brenner R.P. Electroencephalography in syncope. J Clin Neurophysiol 14 (1997) 197-209
34. Grubb B.P., Gerard G., Roush K., et al. Differentiation of convulsive syncope and epilepsy with head-up tilt testing. Ann Intern Med 115 (1991) 871-876
35. Lin J.T., Zeigler D.K., and Lai CW Bayer W. Convulsive syncope in blood donors. Ann Neurol 11 (1982) 523-528
36. Patel S.J., Jackson G., and Marshall A. Convulsive syncope in young adults: think of a cardiac cause. Int J Clin Pract 55 (2001) 639-640
37. Eiris-Punal J., Rodriguez-Nunez A., Fernandez-Martinez N., et al. Usefulness of head-upright tilt test for distinguishing between syncope and epilepsy in children. Epilepsia 42 (2001) 709-713
38. Vicenzini E., Pro S., Strano S., et al. Combined transcranial Doppler and EEG recording in vasovagal syncope. Eur Neurol 60 5 (2008) 258-263
39. Ganzeboom K.S., Colman N., Reitsma J.B., et al. Prevalence and triggers of syncope in medical students. Am J Cardiol 91 (2003) 1006-1008
40. Linzer M., Yang E.H., Estes III N.A., et al. Part 1. Value of history, physical examination and electrocardiography. Clinical efficacy assessment project of the American College of Physicians. Ann Intern Med 126 (1997) 989-996
41. Schnipper J.L., and Kapoor W.N. Diagnostic evaluation and management of patients with syncope. Med Clin North Am 85 (2001) 423-456
42. Brignole M., Alboni P., Benditt D., et al. Task force on syncope, European Society of Cardiology. Part 2. Diagnostic tests and treatment: summary of recommendations. Europace 3 (2001) 261-268
43. Brignole M., Menozzi C., Lolli G., et al. Long-term outcome of paced and nonpaced patients with severe carotid sinus syndrome. Am J Cardiol 69 (1992) 1039-1043
44. Humm A.M., and Mathias C.J. Unexplained syncope-is screening for carotid sinus hypersensitivity indicated in all patients aged >40 years?. J Neurol Neurosurg Psychiatr 77 11 (2006) 1267-1270
45. Kenny R.A., Ingram A., Bayliss J., et al. Head-up tilt: a useful test for investigating unexplained syncope. Lancet 1 (1986) 1352-1355
46. Schondorf R., Benoit J., and Stein R. Cerebral autoregulation in orthostatic intolerance. Ann N Y Acad Sci 940 (2001) 514-526
47. Gatzoulis K.A., and Toutouzas P.K. Neurocardiogenic syncope, aetiology and management. Drugs 61 (2001) 1415-1423
48. Benditt D.G., Ferguson D.W., Grubb B.P., et al. Tilt table testing for assessing syncope. American College of Cardiology expert consensus document. J Am Coll Cardiol 28 (1996) 263-275
49. Sutton R. How and when to pace in vasovagal syncope. J Cardiovasc Electrophysiol 13 Suppl 1 (2002) S4-S16
50. Leman R.B., Clarke E., and Gillette P. Significant complications can occur with ischemic heart disease and tilt table testing. Pacing Clin Electrophysiol 22 (1999) 675-677
51. Davis T.L., and Freemon F.R. Electroencephalography should not be routine in the evaluation of syncope in adults. Arch Intern Med 150 (1990) 2027-2029
52. El-Sayed H., and Hainsworth R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 75 (1996) 134-140
53. Shannon J.R., Diedrich A., Biaggioni I., et al. Water drinking as a treatment for orthostatic syndromes. Am J Med 112 (2002) 355-360
54. Calkins H. Pharmacological approaches to therapy for vasovagal syncope. Am J Cardiol 84 (1999) 20Q-25Q
55. Cox M.M., Perlman B.A., Mayor M.R., et al. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol 26 (1995) 1293-1298
56. Natale A., Sra J., Dhala A., et al. Efficacy of different treatment strategies for neurocardiogenic syncope. Pacing Clin Electrophysiol 18 (1995) 655-662
57. Mahanonda N., Bhuripanyo K., Kangkagate C., et al. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 130 (1995) 1250-1253
58. Madrid A.H., Ortega J., Rebollo J.G., et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo controlled study. J Am Coll Cardiol 37 (2001) 554-559
59. Sheldon R., Connolly S., Rose S., et al. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 113 (2006) 1164-1170
60. Raj S.R., Rose S., Ritchie D., et al. The second prevention of syncope trial (POST II)-a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design. Am Heart J 151 6 (2006) 1186.e11-1186.e17
61. Di Girolamo E., Di Iorio C., Sabatini P., et al. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 33 (1999) 1227-1230
62. Ward C.R., Gray J.C., Gilroy J.J., et al. Midodrine: a role in the management of neurocardiogenic syncope. Heart 79 (1998) 45-49
63. Morillo C.A., Leitch J.W., Yee R., et al. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 22 (1993) 1843-1848
64. Raviele A., Brignole M., Sutton R., et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The vasovagal syncope international study. Circulation 99 (1999) 1452-1457
65. Reybrouck T., Heidbuchel H., Van de Werf F., et al. Tilt training: a treatment for malignant and recurrent neurocardiogenic syncope. Pacing Clin Electrophysiol 23 (2000) 493-498
66. Krediet C.T., van Dijk N., Linzer M., et al. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 106 (2002) 1684-1689
67. van Dijk N., Quartieri F., Blanc J.J., et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the physical counterpressure manoeuvres trial (PC-Trial). J Am Coll Cardiol 48 (2006) 1652-1657
68. Krediet C.T., Go-Schön I.K., van Lieshout J.J., et al. Optimizing squatting as a physical maneuver to prevent vasovagal syncope. Clin Auton Res 18 4 (2008) 179-186
69. Connolly S.J., Sheldon R., Roberts R.S., et al. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 33 (1999) 16-20
70. Ammirati F., Colivicchi F., and Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation 104 (2001) 52-57
71. Connolly S.J., Sheldon R., Thorpe K.E., et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: second vasovagal pacemaker study (VPS II): a randomized trial. JAMA 289 (2003) 2224-2229
72. Raviele A., Giada F., Menozzi C., et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J 25 (2004) 1741-1748
73. Sud S., Massel D., Klein G.J., et al. The expectation effect and cardiac pacing for refractory vasovagal syncope. Am J Med 120 1 (2007) 54-62
74. Reeves A.L., Nollet K.E., Klass D.W., et al. The ictal bradycardia syndrome. Epilepsia 37 (1996) 983-987
75. Schuele S.U., Bermeo A.C., Locatelli E., et al. Ictal asystole: a benign condition?. Epilepsia 49 1 (2008) 168-171
76. Tinuper P., Bisulli F., Cerullo A., et al. Ictal bradycardia in partial epileptic seizures: autonomic investigation in three cases and literature review. Brain 124 (2001) 2361-2371
77. Keilson M., Hauser W., Magrill J., et al. ECG abnormalities in patients with epilepsy. Neurology 37 (1987) 1624-1626
78. Locatelli E.R., Varghese J.P., Shuaib A., et al. Cardiac asystole and bradycardia as a manifestation of left temporal lobe complex partial seizure. Ann Intern Med 130 (1999) 581-583
79. Tatum W.O., Winters L., Gieron M., et al. Outpatient seizure identification. Result of 502 patients using computer-assisted ambulatory EEG. J Clin Neurophysiol 18 (2001) 14-19
80. Chadwick D., and Smith D. The misdiagnosis of epilepsy. Br Med J 24 (2002) 495-496
81. Scheepers B., Clough P., and Pickles C. The misdiagnosis of epilepsy: findings of a population study. Seizure 5 (1998) 403-406
82. Smith D., Defalla B.A., and Chadwick D.W. The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic. QJM 92 (1999) 15-23
83. Grubb B.P., and Kosinski D.J. Syncope resulting from autonomic insufficiency syndromes associated with orthostatic intolerance. Med Clin North Am 85 (2001) 457-472
84. Mathias C.J. Orthostatic hypotension: causes, mechanisms, and influencing factors. Neurology 45 Suppl 5 (1995) S6-S11
85. Shibao C., Grijalva C.G., Raj S.R., et al. Orthostatic hypotension-related hospitalizations in the United States. Am J Med 120 (2007) 975-980
86. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The consensus committee of the American Autonomic Society and the American Academy of Neurology. Neurology 46 (1996) 1470
87. Low P.A. The effect of aging on the autonomic nervous system. In: Low P.A. (Ed). Clinical autonomic disorders. 2nd edition (1997), Lippincott-Raven, Philadelphia 161-175
88. Robertson D., Kincaid D.W., Haile V., et al. The head and neck discomfort of autonomic failure: an unrecognized aetiology of headache. Clin Auton Res 4 (1994) 99-103
89. Gibbons C.H., and Freeman R. Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology 67 (2006) 28-32
90. Streeten D.H., and Anderson G.H. Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. Am J Hypertens 9 (1996) 760-769
91. Freeman R. Autonomic peripheral neuropathy. Neurol Clin 25 1 (2007) 277-301
92. Weimer LH. Neurogenic orthostatic hypotension, autonomic failure, and autonomic neuropathy. In: Rowland LP, Pedley TA, editors. Merritt's neurology. 12th edition. Philadelphia: Lippincott Williams & Wilkins, in press.
93. Weimer L.H. Syncope and orthostatic intolerance for the primary care physician. Prim Care 31 1 (2004) 175-199
94. Ewing D.J., Campbell I.W., and Clarke B.F. The natural history of diabetic autonomic neuropathy. Q J Med 49 (1980) 95-108
95. Rathman W., Ziegler D., Jahnke M., et al. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 10 (1993) 820-824
96. Gerritsen J., Dekker J.M., TenVoorde B.J., et al. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the hoorn study. Diabetes Care 24 (2001) 1793-1798
97. Bergethon P.R., Sabin T.D., and Lewis D. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 47 (1996) 944-951
98. Suarez G.A., Fealey R.D., Camilleri M., et al. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 44 9 (1994) 1675-1682
99. Etienne M., and Weimer L.H. Immune-mediated autonomic neuropathies. Curr Neurol Neurosci Rep 6 1 (2006) 57-64
100. Schondorf R., and Low P.A. Idiopathic postural orthostatic tachycardia syndrome. An attenuated form of acute pandysautonomia?. Neurology 43 (1993) 132-137 [STOP]
101. Vernino S., Adamski J., Kryzer T.J., et al. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 50 (1998) 1806-1813
102. Vernino S., Low P.A., Fealey R.D., et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 343 (2000) 847-855
103. Heafield M.T.E., Gammage M.D., Nightingale S., et al. Idiopathic dysautonomia treated with intravenous gammaglobulin. Lancet 347 (1996) 28-29
104. Smit A.A.J., Vermeulen M., Koelman H.T.M., et al. Unusual recovery from acute panautonomic neuropathy after immunoglobulin therapy. Mayo Clin Proc 72 (1997) 333-335
105. Zochodne D.W. Autonomic involvement in Guillain-Barré syndrome: a review. Muscle Nerve 17 (1994) 1145-1155
106. Camdessanche J.P., Antoine J.C., Honnorat J., et al. Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain 125 (2002) 166-175
107. Gilman S., Wenning G.K., Low P.A., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71 9 (2008) 670-676
108. Magalhães M., Wenning G.K., Daniel S.E., et al. Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease-a retrospective comparison. Acta Neurol Scand 91 (1995) 98-102
109. Biaggioni I., and Robertson D. Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 2 (1987) 1170-1172
110. Hague K., Lento P., Morgello S., et al. The distribution of Lewy bodies in pure autonomic failure: autopsy findings and review of the literature. Acta Neuropathol 94 (1997) 192-196
111. Biaggioni I., Hollister A.S., and Robertson D. Dopamine in dopamine-beta-hydroxylase deficiency. N Engl J Med 317 (1987) 1415-1416
112. Mathias C.J., Senard J.M., Braune S., et al. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 11 (2001) 235-242
113. Assessment: clinical autonomic testing report of the therapeutics and technology assessment subcommittee of the American Association of Neurology. Neurology 46 (1996) 873-880
114. Hilz M.J., and Dutsch M. Quantitative studies of autonomic function. Muscle Nerve 33 1 (2006) 6-20
115. Freeman R. Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med 358 6 (2008) 615-624
116. Mathias C.J., and Young T.M. Water drinking in the management of orthostatic intolerance due to orthostatic hypotension, vasovagal syncope and the postural tachycardia syndrome. Eur J Neurol 11 9 (2004) 613-619
117. Thijs R.D., Wieling W., van den Aardweg J.G., et al. Respiratory countermaneuvers in autonomic failure. Neurology 69 6 (2007) 582-585
118. Jankovic J., Gilden J.L., Hiner B.C., et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. JAMA 95 (1993) 38-48
119. Vagaonescu T.D., Saadia D., Tuhrim S., et al. Hypertensive cardiovascular damage in patients with primary autonomic failure. Lancet 355 (2000) 725-726
120. Singer W., Sandroni P., Opfer-Gehrking T.L., et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 63 (2006) 513-518
121. Low P.A., Opfer-Gehrking T.L., Textor S.C., et al. Postural tachycardia syndrome (POTS). Neurology 45 4 (1995) S19-S25
122. Jacob G., and Biaggioni I. Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J Med Sci 317 (1999) 88-101
123. Medow M.S., and Stewart J.M. The postural tachycardia syndrome. Cardiol Rev 15 2 (2007) 67-75
124. Shannon J.R., Flattem N.L., Jordan J., et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 342 8 (2000) 541-549
125. Schroeder C., Tank J., Boschmann M., et al. Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance. Circulation 105 (2002) 347-353
126. Legge H., Norton M., and Newton J.L. Fatigue is significant in vasovagal syncope and is associated with autonomic symptoms. Europace 10 9 (2008) 1095-1101
127. Rowe P.C., Bou-Holaigah I., Kan J.S., et al. Is neurally mediated hypotension an unrecognized cause of chronic fatigue?. Lancet 345 (1995) 623-624
128. Jones J.F., Nicholson A., Nisenbaum R., et al. Orthostatic instability in a population-based study of chronic fatigue syndrome. Am J Med 118 12 (2005) 1415
129. Rowe P.C., Calkins H., DeBusk K., et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 285 (2001) 52-59
130. Taylor A.A., Davies A.O., Mares A., et al. Spectrum of dysautonomia in mitral valve prolapse. Am J Med 86 (1989) 267-274
131. Garland E.M., and Robertson D. Chiari I malformation as a cause of orthostatic intolerance symptoms: a media myth?. Am J Med 111 (2001) 546-552